Posts by Brian Westerlind
Webinar Review: FDA’s View on Compliance
On May 24, 2016, the American Association of Homeopathic Pharmacists hosted the latest in its Compliance through Education webinar series. The webinar featured a presentation from Brad Pace, acting director…
Read MoreFDA Guidance for Industry – Request for Quality Metrics
By Mark Land, AAHP President FDA published its draft guidance, Request for Quality Metrics; Guidance for Industry1. Advancing the background on the initiative in general, this draft reveals 10 mandatory…
Read MoreHomeopathic Drug Labels: Rx or OTC?
By J.P. Borneman, Ph.D. and Alvin J. Lorman Homeopathic drugs, we proudly tell folks, really are drugs: the Federal Food, Drug, and Cosmetic Act has recognized them as such since…
Read MoreDo Your Dosage Forms Appeal to Consumers?
By Eric L. Foxman, R.Ph. Consumers make purchase decisions based on several factors such as packaging and perceived effectiveness. Research shows dosage forms also factor into consumersā€™ decision to buy…
Read MoreWhat’s a Hippus?
Like other over-the-counter drug communities, the homeopathic industry spends thousands of hours each year researching and reviewing the effectiveness and safety of ingredients to be used in homeopathic remedies. All…
Read More2016 Annual Meeting Recap
March, 2016ā€”Thirty-two members of the American Association of Homeopathic Pharmacists (AAHP) came together to discuss the most pressing industry issues as well as the associationā€™s current programs and initiatives. The…
Read More